No, the Dexcom Follow app does not work with the Dexcom G6 Pro System.
No, the Dexcom Follow app does not work with the Dexcom G6 Pro System.
The Dexcom G6 app will automatically configure which features are available for a user, depending on whether the transmitter is part of the Dexcom G6 CGM System or Dexcom G6 Pro CGM System. As many patients on Dexcom G6 Pro are new to CGM, the app will configure to offer basic features, such as glucose data, event entry, high and low alerts, and the Urgent Low alarm. Advanced features, such as Share/Follow, fast rise/fall rate alerts, and alert schedules are not supported in Dexcom G6 Pro.
Feature | Dexcom G6 Pro | Dexcom G6 |
System | ||
Indication | 2 years or older | 2 years or older |
Duration of wear | Up to 10 days | Up to 10 days |
Calibration | Not required | Not required |
eMode | Unblinded or Blinded | Unblinded |
Dosing | Non-adjunctive | Non-adjunctive |
Retrospective | ||
Software | Dexcom CLARITY | Dexcom CLARITY |
Display (Unblinded mode) | ||
Device | Smartphone* | Smartphone* or Dexcom Receiver |
Dexcom G6 App | Basic features | Advanced features |
Transmitter | ||
Use | Disposable | Reusable (up to 3 months) |
Start | Auto-start | Manual start |
Sensor | ||
Acetaminophen Blocking | Yes† | Yes† |
Applicator | ||
Insertion | Auto | Auto |
*Patient must have a compatible smart phone for an unblinded mode session. To view a list of compatible devices, visit dexcom.com/compatibility.
† Dexcom G6 and G6 Pro (when used in unblinded mode) readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000 mg every 6 hours. Taking a higher dose may affect Dexcom G6 readings.
The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is a real-time continuous glucose monitoring device indicated for the management of diabetes in persons age 2 years and older in a home environment while under the supervision of a healthcare provider. The Dexcom G6 Pro CGM System is intended to replace fingerstick blood glucose testing for diabetes treatment decisions.* Interpretation of the real-time Dexcom G6 Pro CGM System results should be based on the glucose trends and several sequential readings over time.*
The Dexcom G6 Pro CGM System may also be used as a retrospective glucose recording device indicated for assessing glycemic variability in persons ages 2 years and older in a home environment, while under the supervision of a healthcare provider. Retrospective interpretation of data recorded by the Dexcom G6 Pro CGM System should be conducted solely by a healthcare professional.
The Dexcom G6 Pro CGM System aids in detecting glucose excursions facilitating care plan adjustments. The Dexcom G6 Pro CGM System is also intended to interface with digitally connected devices. The Dexcom G6 Pro CGM System can be used alone or in conjunction with these digitally connected medical devices for managing diabetes* or assessing glycemic variability.
*when used in unblinded mode
Each Dexcom G6 Pro sensor can be worn for up to 10 days.
The Dexcom G6 Pro transmitter records data up to 10 days. At the end of the session, a healthcare provider has up to 30 days from the CGM insertion date to extract data from the transmitter, using the reader. The Dexcom G6 Pro transmitter is disposable and cannot be reused.
The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is the latest professional CGM system created by Dexcom for healthcare providers (HCPs). Dexcom G6 Pro is factory-calibrated—zero fingersticks required.* Dexcom G6 Pro features a onetouch auto-applicator and a single-use, disposable transmitter that auto-starts. The Dexcom G6 Pro CGM System is comprised of a sensor, transmitter, and (if used in unblinded mode) the Dexcom G6 app. In unblinded mode, Dexcom G6 Pro sends glucose readings to a patient’s compatible smart device every five minutes. Dexcom G6 Pro is indicated for patients ages 2 years and older.
*If your glucose alerts and readings from Dexcom G6 Pro do not match symptoms or expectations (when used in unblinded mode), use a blood glucose meter to make diabetes treatment decisions.
†Patient must have a compatible smart phone for an unblinded mode session. To view a list of compatible devices, visit dexcom.com/compatibility